StockMarketWire.com - Morgan Stanley today reaffirms its equal weight investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 6400p (from 5250p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk